Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease

Journal of Neurochemistry

Volumn 76, Issue 1, 2001, Pages 166-172

  Morton, A J ^a   Edwardson, J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Complexin II; Huntington's disease; Neurodegeneration; SNARE; Transgenic mouse

Indexed keywords

BRAIN PROTEIN; COMPLEXIN II; NEUROTRANSMITTER; SNARE PROTEIN; UNCLASSIFIED DRUG;

AFFECTIVE NEUROSIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; DEGENERATIVE DISEASE; EXOCYTOSIS; GENE MUTATION; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AGING; ANIMALS; BRAIN; CARRIER PROTEINS; CELL NUCLEUS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUNTINGTON DISEASE; INCLUSION BODIES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; ORGAN SPECIFICITY; SNARE PROTEINS; SOLUBLE N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEINS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES; VESICULAR TRANSPORT PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 0035158533     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00059.x     Document Type: Article

References (34)

1. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation
2. Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease
3. A novel function for the second C2 domain of synaptotagmin
4. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
5. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction of mice transgenic for the HD mutation
6. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
7. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
8. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers
9. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia
10. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
11. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
12. Membrane fusion and exocytosis
13. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
14. Evidence for specific cognitive deficits in preclinical Huntington's disease
15. A huntingtin-associated protein enriched in brain with implications for pathology
16. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation
17. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
18. Complexins: Cytosolic proteins that regulate SNAP receptor function
19. Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models
20. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for the human Huntington's disease mutation
21. Clinical and neuropathologic assessment of severity in Huntington's disease
22. Regulatory roles of complexins in neurotransmitter release from mature presynaptic nerve terminals
23. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressively late onset neurological phenotype in the mouse
24. Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation
25. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
26. Motor disorder in Huntington's disease begins as a dysfunction in error feedback control
27. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone
28. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution
29. Reduced hippocampal LTP in mice lacking a presynaptic protein: Complexin II
30. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation
31. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways
32. Huntington disease
33. Immunohistochemical distribution of the two isoforms of synaphin/complexin involved in neurotransmitter release: Localization at the distinct central nervous system regions and synaptic types
34. Characterization of the mouse Src homology domain gene Sh3d2c on chr 7 demonstrates coexpression with huntingtin in the brain and identifies the processed pseudogene Sh3d2c-ps1 on chr 2